[Functional/metabolic CAD diagnosis: arbutamine-RNV, stress-Echo, Tl-SPECT and gated FDG-PET].
In this report we discuss the abilities of intercorrelative cardiovascular nuclear medicine to detect and characterize myocardial perfusion anomalies and viable myocardium in a 58-year-old patient before revascularization.
Adams
S
S
Klinik für Nuklearmedizin, Frankfurt, Deutschland.
Baum
R P
RP
Scholz
M
M
Zeiher
A M
AM
Hör
G
G
D002395:Catecholamines; D003327:Coronary Disease / Q000175:diagnosis* / Q000000981:diagnostic imaging; D003847:Deoxyglucose / Q000031:analogs & derivatives*; D004452:Echocardiography; D005080:Exercise Test; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D015637:Gated Blood-Pool Imaging; D006321:Heart / Q000000981:diagnostic imaging* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009204:Myocardial Revascularization; D009206:Myocardium / Q000378:metabolism; D013902:Radiography, Thoracic; D015635:Radionuclide Ventriculography; D013794:Thallium Radioisotopes; D015899:Tomography, Emission-Computed, Single-Photon
D002395:Catecholamines; D005462:Fluorine Radioisotopes; D013794:Thallium Radioisotopes; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose; C076559:arbutamine